Fundz

Remedium Bio Inc. reported raising $1.37 Million in an initial SEC Form D filing, from an offering of $2.3 Million

PRIVATENov 09, 2021$1.4M of $2.3M raised

Amount Raised

$1.37 Million

$1.37 Million sold, per SEC Form D (first sale Nov 9, 2021)

Round Type

Seed

BostonBiotechnologyHealth CareTherapeutics

Quick answer

Remedium Bio raised $1.37 Million in a Seed round, dated November 9, 2021. Remedium Bio is based in Boston, Massachusetts, United States.

How much did Remedium Bio raise?
Remedium Bio raised $1.37 Million in a Seed round on November 9, 2021.
What does Remedium Bio do?
Remedium Bio is a gene therapy company focused on the development of treatments for large unmet clinical needs.
Where is Remedium Bio based and how big is it?
Remedium Bio is based in Boston, Massachusetts, United States.
Who are the decision-makers at Remedium Bio?
Fundz holds 1 contact at Remedium Bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Remedium Bio that raised within 45 days of this round, from Fundz verified event records.

  • Arcutis raised $225M (Debt Financing) on December 23, 2021.
  • Galectin raised an undisclosed amount (Debt Financing) on December 21, 2021.
  • AnHeart Therapeutics raised $61M (Series B) on December 14, 2021.
  • Biofrontera raised $15M on December 10, 2021.
  • AEON Biopharma raised $30M on December 8, 2021.
  • CytoDyn raised $11M on December 3, 2021.

Who to call at Remedium Bio, and when

A new round usually means Remedium Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Remedium Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Remedium Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Remedium Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Remedium Bio

Location

Boston, Massachusetts, United States

About

Remedium Bio is a gene therapy company focused on the development of treatments for large unmet clinical needs. To enable this, we developed a revolutionary gene therapy platform technology, which enables safe, effective, and durable delivery of therapeutic genes while allowing for simple post-treatment dose adjustment. The Prometheus™ adjustable gene therapy platform is able to safely and durably replace multi-injection subcutaneously administered biologics, with a single treatment, at a fraction of the cost, and without genetic integration. Our lead product is a disease-modifying treatment for Osteoarthritis that is based on the only clinically validated chondro-regenerative mechanism. Remedium’s pipeline includes gene therapy treatments in the fields of Weight Loss, Type 2 Diabetes, and Stroke.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Remedium Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts1 person is listed at Remedium Bio. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Remedium Bio's next move

See what Strategic adds

Remedium Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.